Life Sciences Market - Industry overview, Trends & Report

sale

Global Therapeutic Vaccines Market

P

2024

Global Therapeutic Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global global therapeutic vaccines market was valued at $26.7 billion in 2023, and is projected to reach $135.7 billion by 2033, growing at a CAGR of 19.1% from 2024 to 2033.

Report Code : A00074 | Pages : 300 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Vaccines Market

P

2024

Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2023 - 2035

The global vaccines market was valued at $43.2 billion in 2023, and is projected to reach $90.7 billion by 2035, growing at a CAGR of 6.4% from 2024 to 2035.

Report Code : * A00168 | Pages : 350 | Category : Life Sciences

Price:

~~$3,840~~ $2,688 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Meningococcal Vaccine Market

P

2020

Meningococcal Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2018–2026

The global meningococcal vaccine market size was valued at $1,935.5 million in 2018, and is projected to reach $4,192.6 million by 2026, registering a CAGR of 9.5% from ...

Report Code : A00240 | Pages : 197 | Category : Life Sciences

Price:

~~$3,456~~ $2,765 (20% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

DNA Vaccine Market

P

2021

DNA Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2021–2030.

The global DNA vaccine market size was valued at $422.77 Million in 2020 and is projected to reach $774.43 Million by 2030 registering a CAGR of 6.3% from ...

Report Code : A00549 | Pages : 123 | Category : Life Sciences

Price:

~~$3,712~~ $2,784 (25% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Live Cell Imaging Market

P

2023

Live Cell Imaging Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global live cell imaging market was valued at $2.3 billion in 2022, and is projected to reach $5.2 billion by 2032, growing at a CAGR of 8.2% from 2023 to 2032.

Report Code : A00662 | Pages : 285 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Influenza Vaccine Market

P

2021

Influenza Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

An influenza vaccine is a vaccine designed to protect against the influenza virus, commonly known as the flu, which comes in trivalent or quadrivalent types, used to treat seasonal and pandemic flu. It is based on egg-based and cell-based technology, used for adults and pediatric as well.

Report Code : A01118 | Pages : 217 | Category : Life Sciences

Price:

~~$3,712~~ $2,784 (25% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Cancer Vaccines Market

P

2020

Cancer Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.

Report Code : A01134 | Pages : 284 | Category : Life Sciences

Price:

~~$3,456~~ $2,627 (24% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Animal Vaccines Market

P

2021

Animal Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

The global animal vaccines market size was valued at $9,093.9 million in 2020, and is projected to reach $15,201.5 million by 2030, registering a CAGR of 5.2% from ...

Report Code : A01658 | Pages : 234 | Category : Life Sciences

Price:

~~$3,712~~ $2,821 (24% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Conjugate Vaccines Market

U

2026

Conjugate Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein. This protein has a key role in enhancing ...

Report Code : A02556 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Varicella Live Vaccine Market

P

2019

Varicella Live Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2018–2026

The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026.

Report Code : A03624 | Pages : 178 | Category : Life Sciences

Price:

~~$3,456~~ $2,350 (32% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Aquaculture Vaccines Market

U

2026

Aquaculture Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Summary The scope of the report focuses on the potential industry players operating in the Aquaculture vaccines market and their relative share. In addition, it provides in-depth analysis of the market, outlining the company profiles, produ

Report Code : A10284 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Live Cell Encapsulation Market

U

2026

Live Cell Encapsulation Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Live cell encapsulation market is experiencing growth due to increase in the investments made for new therapeutics and rise in chronic diseases. Live cell encapsulation in future is ...

Report Code : A10863 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Dengue Vaccines Market

U

2026

Dengue Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Dengue is a mosquito-borne infectious disease that affects both animals and humans, it is caused by the dengue virus that belongs to the family of Flaviviridae and genus Flavivirus.

Report Code : A14321 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Recombinant Vaccines Market

P

2022

Recombinant Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global recombinant vaccines market was valued at $8.1 billion in 2021, and is projected to reach $24.7 billion by 2031, growing at a CAGR of 11.4% from 2022 to 2031.

Report Code : A17605 | Pages : 258 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Live Cell Imaging Market

M

2025

Live Cell Imaging Market:

Scope Of The Study The report covers a micro-level study of different product type, application, end user. Region wise, the report includes the Live cell imaging market trends across North America, Europe, Asia-Pacific, and LAMEA. In addition, the

Report Code : A177853 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Brucellosis Vaccines Market by Type

P

2024

Brucellosis Vaccines Market by Type : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global brucellosis vaccines market was valued at $0.2 billion in 2023, and is projected to reach $0.4 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033.

Report Code : A324385 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Europe Vaccines Market

P

2024

Europe Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Europe vaccines market was valued at $12.1 billion in 2023, and is projected to reach $22.3 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.

Report Code : A325349 | Pages : 150 | Category : Life Sciences

Price:

~~$2,257~~ $1,580 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Vaccines Market

P

2024

U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Report Code : A325351 | Pages : 90 | Category : Life Sciences

Price:

~~$2,177~~ $1,524 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

UK Vaccines Market

P

2024

UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The UK vaccines market was valued at $1.4 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

Report Code : A325352 | Pages : 150 | Category : Life Sciences

Price:

~~$1,991~~ $1,394 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Vaccines Market

P

2024

Australia Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Report Code : A325353 | Pages : 90 | Category : Life Sciences

Price:

~~$1,859~~ $1,301 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Life Sciences

Filter by Region

Filter by Discounts

Filter by Category

The global global therapeutic vaccines market was valued at $26.7 billion in 2023, and is projected to reach $135.7 billion by 2033, growing at a CAGR of 19.1% from 2024 to 2033.

The global vaccines market was valued at $43.2 billion in 2023, and is projected to reach $90.7 billion by 2035, growing at a CAGR of 6.4% from 2024 to 2035.

The global meningococcal vaccine market size was valued at $1,935.5 million in 2018, and is projected to reach $4,192.6 million by 2026, registering a CAGR of 9.5% from ...

The global DNA vaccine market size was valued at $422.77 Million in 2020 and is projected to reach $774.43 Million by 2030 registering a CAGR of 6.3% from ...

The global live cell imaging market was valued at $2.3 billion in 2022, and is projected to reach $5.2 billion by 2032, growing at a CAGR of 8.2% from 2023 to 2032.

An influenza vaccine is a vaccine designed to protect against the influenza virus, commonly known as the flu, which comes in trivalent or quadrivalent types, used to treat seasonal and pandemic flu. It is based on egg-based and cell-based technology, used for adults and pediatric as well.

The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.

The global animal vaccines market size was valued at $9,093.9 million in 2020, and is projected to reach $15,201.5 million by 2030, registering a CAGR of 5.2% from ...

Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein. This protein has a key role in enhancing ...

The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026.

Report Summary The scope of the report focuses on the potential industry players operating in the Aquaculture vaccines market and their relative share. In addition, it provides in-depth analysis of the market, outlining the company profiles, produ

Live cell encapsulation market is experiencing growth due to increase in the investments made for new therapeutics and rise in chronic diseases. Live cell encapsulation in future is ...

Dengue is a mosquito-borne infectious disease that affects both animals and humans, it is caused by the dengue virus that belongs to the family of Flaviviridae and genus Flavivirus.

The global recombinant vaccines market was valued at $8.1 billion in 2021, and is projected to reach $24.7 billion by 2031, growing at a CAGR of 11.4% from 2022 to 2031.

Scope Of The Study The report covers a micro-level study of different product type, application, end user. Region wise, the report includes the Live cell imaging market trends across North America, Europe, Asia-Pacific, and LAMEA. In addition, the

The global brucellosis vaccines market was valued at $0.2 billion in 2023, and is projected to reach $0.4 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033.

The Europe vaccines market was valued at $12.1 billion in 2023, and is projected to reach $22.3 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.

The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

The UK vaccines market was valued at $1.4 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.